Merck invests $110 million to expand production site in China
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors
Under the terms of the agreement, Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
Support for biologics manufacturability and Industry 4.0 initiatives
Subscribe To Our Newsletter & Stay Updated